BBPvsARKGETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.75% for ARKG. BBP is up 9.25% year-to-date (YTD) with +$30M in YTD flows. ARKG performs better with 14.68% YTD performance, and -$93M in YTD flows. Run a side-by-side ETF comparison of BBP and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP ARKG | -1.38%+12.70% | +7.00%+27.93% | +9.25%+14.68% | +43.65%+41.38% | +60.05%-2.11% | +58.90%-61.48% |
| Flows | BBP ARKG | +$4M-$66M | +$26M-$83M | +$30M-$93M | +$42M-$80M | +$45M-$636M | +$38M-$2.66B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP ARKG | +28.75%+45.22% | +24.06%+41.97% | +24.00%+43.21% | +26.36%+45.71% |
| Max drawdown | BBP ARKG | -7.49%-10.02% | -9.59%-27.52% | -25.54%-51.98% | -37.87%-80.16% |
| Max drawdown duration | BBP ARKG | 37d35d | 48d126d | 292d1059d | 760d1809d |
Trading data
BBP | ARKG | |
Last sale 6/12/2026 at 1:30 PM | $87.17 | $33.47 |
| Previous close 06/11/2026 | $86.80 | $33.65 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexBBP | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
BBP | ARKG | |
|---|---|---|
| Last price | $87.17 | $33.47 |
| 1D performance | +0.42% | -0.53% |
| AuM | $78.43 M | $1.24 B |
| E/R | 0.79% | 0.75% |
Characteristics
BBP | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Ark Investment |
| Benchmark | LifeSci Biotechnology Products Index | - |
| N° of holdings | 55 | 27 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
84.13%
Other
15.87%
ARKG
USA
68.62%
Switzerland
8.97%
Other
22.41%
Sectors
BBP
Health Care
85.97%
Other
14.03%
ARKG
Health Care
76.57%
Other
23.43%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
45.32%
ARKG
Total weight of top 15 holdings out of 15
60.37%
Top 15 holdings
Data as of April 30, 2026
BBP
ARROWHEAD PHARMACEUTICALS INC
3.17%
GB00BRXB0C07
3.17%
BIOGEN INC
3.14%
HALOZYME THERAPEUTICS
3.13%
AURINIA PHARMACEUTICALS INC
3.12%
SYNDAX PHARMACEUTICALS INC
3.12%
BIOMARIN PHARMACEUTICAL
3.05%
INCYTE
3.03%
REGENERON PHARMACEUTICALS
3.03%
BRIDGEBIO PHARMA
3.00%
SAREPTA THERAPEUTICS INC DE
2.95%
ARDELYX
2.92%
VERTEX PHARMACEUTICALS
2.85%
US07725L1026
2.83%
THERAVANCE BIOPHARMA
2.80%
ARKG
CRISPR THERAPEUTICS
8.97%
10X GENOMICS INC
5.66%
BEAM THERAPEUTICS
5.54%
ABSCI
4.73%
ILLUMINA
4.08%
NATERA
4.00%
PERSONALIS INC
3.61%
CAREDX INC/D
3.61%
RECURSION PHARMACEUTICALS
3.51%
INTELLIA THERAPEUTICS INC
3.40%
GUARDANT HEALTH INC
3.38%
VERACYTE INC/D
2.74%
ADAPTIVE BIOTECHNOLOGIES
2.44%
NURIX THERAPEUTICS
2.41%
COMPASS PATHWAYS ADR
2.29%
Frequently asked questions about BBP and ARKG
How have the BBP and ARKG ETFs performed in 2026?
As of June 12, 2026, BBP is up 9.25% year-to-date (YTD), while ARKG has returned 14.68%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or ARKG?
Year-to-date, the BBP ETF saw +$30M in flows, compared to -$93M for ARKG.
Which ETF is more volatile: BBP or ARKG?
Over the past year, BBP had a volatility of 24.06%, while ARKG experienced 41.97%.
Which ETF is bigger: BBP or ARKG?
As of June 12, 2026, BBP holds $78.43 M in assets under management (AUM), while ARKG manages $1.24 B.
What sectors do the BBP and ARKG ETFs invest in?
BBP leans toward sectors like Health Care. Meanwhile, ARKG focuses on Health Care.
What are the top holdings of the BBP ETF and ARKG ETF?
BBP top holdings include ARROWHEAD PHARMACEUTICALS INC, GB00BRXB0C07 and BIOGEN INC. ARKG holds in its top three: CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS.
Which ETF is more diversified: BBP or ARKG?
BBP holds 59 securities with 45.32% of its assets in the top 15. ARKG has 27 securities and a top 15 weight of 60.37%.
Advertisement
Latest news about BBP & ARKG
Advertisement
